Orabloc Injection
NDC Package 45146-110-01
Package Information
Orabloc (articaine hydrochloride and epinephrine bitartrate) injection is orabloc® is an amide local anesthetic containing a vasoconstrictor indicated for local, infiltrative, or conductive anesthesia in both simple and complex dental procedures. This formulation utilizes a injection delivery system. Marketed by Pierrel S.p.a., this product is identified by NDC 45146-110 and is authorized under FDA application NDA022466.
Identification & Billing
- RxCUI: 1091068 - Orabloc 4 % / 1:100,000 in 1.8 mL Dental Cartridge
- RxCUI: 1091068 - 1.8 ML articaine hydrochloride 40 MG/ML / epinephrine 0.01 MG/ML Cartridge [Orabloc]
- RxCUI: 1091072 - Orabloc 4 % / 1:200,000 in 1.8 mL Dental Cartridge
- RxCUI: 1091072 - 1.8 ML articaine hydrochloride 40 MG/ML / epinephrine 0.005 MG/ML Cartridge [Orabloc]
- RxCUI: 1091072 - Orabloc 4 % / 1:200,000 (articaine HCl / epinephrine (as epinephrine bitartrate)) 1.8 ML Cartridge
Clinical Specifications
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Local Anesthesia - [PE] (Physiologic Effect)
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 45146 - Pierrel S.p.a.
- 45146-110 - Orabloc
- 45146-110-01 - 100 CARTRIDGE in 1 BOX / 1.8 mL in 1 CARTRIDGE
- 45146-110 - Orabloc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (45146-110). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45146-110-01 identifies a specific commercial package of 100 cartridge in 1 box / 1.8 ml in 1 cartridge of Orabloc, a human prescription drug labeled by Pierrel S.p.a.. This injection is formulated for submucosal use and contains articaine hydrochloride; epinephrine bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pierrel S.p.a. on March 01, 2011. The current certification is valid through December 31, 2026.
How is this Pierrel S.p.a. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45146011001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.